# Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome

> **NCT01625442** · PHASE4 · COMPLETED · sponsor: **Birjand University of Medical Sciences** · enrollment: 732 (actual)

## Conditions studied

- Metabolic Syndrome
- Hypercholesterolemia
- Hypertriglyceridemia
- Hyperglycemia

## Interventions

- **DRUG:** Saffron tablet
- **DRUG:** Barberry tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01625442
- **Lead sponsor:** Birjand University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-07
- **Final completion:** 2012-02
- **Target enrollment:** 732 (ACTUAL)
- **Last updated:** 2012-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01625442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01625442, "Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01625442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*